Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous lysine acetylsalicylate vs oral aspirin in STEMI: platelet responsiveness
2016-000054-35Phase 2Active
- Sponsor
- Fundación Interhospitalaria para la Investigación Cardiovascular
- Start
- May 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of lysine acetylsalicylate and aspirin in myocardial infarction (MI) (2 arms), sponsored by Fundación Interhospitalaria para la Investigación Cardiovascular. Primary endpoint: Platelet reactivity at 30 minutes. Started May 2016; status: active.
02
Drugs
lysine acetylsalicylateaspirin
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on 2016-000054-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-000054-35.